Skip to content
Screener

Share Buybacks at other companies

UnitedHealth Group logo
UnitedHealth GroupUNH
$1.65B-35.3%
Conduent Incorporated logo
Conduent IncorporatedCNDT
$5M
Definitive Healthcare Corp. logo
Definitive Healthcare Corp.DH
$0-100%
Corvel logo
CorvelCRVL
$21.97M+128%
IQVIA logo
IQVIAIQV
$398M-39.4%
Waystar Holding Corp. logo
Waystar Holding Corp.WAY
$0

Other financials

Income statement

See full
Revenue$257.5M+6.6%
Gross profit$189.8M+5.0%
Operating income$23.4M+41.2%
Net income-$59.2M+5.5%
EPS (diluted)-$3.49+8.4%

Balance sheet

See full
Cash & equivalents$27.7M-58.9%
Total debt$4.7B+1.0%
Total equity-$294.6M-638%
Total assets$4.8B-6.1%

Cash flow

See full
Operating cash flow$92.7M+51.3%
CapEx$38.1M+54.7%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$555.59M-45.3%
Enterprise value$5.2B-6.7%
P/S0.6×-0.5×

Profitability

See full
Gross margin73%-1.5pp
Operating margin-0.5%-0.3pp
Net margin-28.5%-10.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio0.0×

Where this comes from

Reported directly by Claritev Corporation in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The source filing: Claritev Corporation’s 10-K, filed February 26, 2026.

Filed
Feb 26, 2026, 6:14 AM EST
Fiscal year
FY2025
Accession
0001793229-26-000017
Line itemYear Ended December 31, 2025Year Ended December 31, 2024Year Ended December 31, 2023
Taxes paid on settlement of vested share awards(4,095)(3,356)(465)
Borrowings on 2025 Revolving Credit Facility230,000
Repayment of 2025 Revolving Credit Facility(210,000)
Purchase of treasury stock(10,370)(15,218)
Payment of debt issuance costs(4,267)(615)
Borrowings on finance leases, net67(30)
Proceeds from issuance of Class A common stock under ESPP1,7421,095508
Net cash provided by (used in) financing activities2,363(41,315)(180,993)

Item 8. Financial Statements and Supplementary Data

FAQ

What is Claritev Corporation's share buybacks?
Claritev Corporation (CTEV) reported share buybacks of $0 in Q4 2025.
What is the long-term trend for Claritev Corporation's share buybacks?
Over 4 years (2021 to 2025), Claritev Corporation's share buybacks has grown at a -100.0% compound annual growth rate (CAGR), from $100M to $0.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Ask your AI about Claritev Corporation's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude